Galectin Therapeutics Announces Pricing of $9.8 Million Registered Direct Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. PCG
2. NVDA
3. AVGO
4. ALNY
5. CNS
6. ATTO
7. BRVE
8. EIX
9. EC
10. APO

Go back to Galectin Therapeutics Announces Pricing of $9.8 Million Registered Direct Offering

Galectin Therapeutics (GALT) Prices 4.76M Securities Purchase Agreement

November 20, 2015 9:04 AM EST

Galectin Therapeutics (NASDAQ: GALT) announced that it has entered into securities purchase agreement with certain institutional investors providing for the purchase and sale of 4,761,900 shares of common stock at a price of $2.06 per share and warrants to purchase up to 3,571,425 shares of common... More